Methotrexate Injectable Suppliers & Bulk Manufacturers

Available Forms: Injectable (IV, IM, Subcutaneous)

Available Strengths: 25 mg/mL, 50 mg/mL, 250 mg/10 mL vial

Reference Brands: Trexall (US)

Category: Arthritis

Methotrexate Injectable is available in Injectable (IV, IM, Subcutaneous) and strengths such as 25 mg/mL, 50 mg/mL, 250 mg/10 mL vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Methotrexate Injectable is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Methotrexate Injectable can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Methotrexate injectable is approved in the EU and US for treating rheumatoid arthritis, cancer, and autoimmune diseases. In the EU, Pfizer’s Trexall and other generics are regulated by EMA, supported by dossiers demonstrating safety, quality, and efficacy. In the US, FDA approval is based on comprehensive clinical data and biosimilarity assessments. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, registration, and compliance, visit PharmaTradz. We support efficient market access for methotrexate injectable formulations, ensuring adherence to European and American standards for safe, effective treatment of autoimmune and oncological conditions.